Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study

Background: The aim of the study was to evaluate the long-term safety and efficacy of the Trabectome for Chinese glaucoma patients. Methods: This was a multicenter, retrospective, observational study. Glaucoma patients, except those with neovascular glaucoma, with/without a visually significant cata...

Full description

Bibliographic Details
Main Authors: Ya-Long Dang, Yu-Jie Cen, Ying Hong, Ping Huang, Ning-Li Wang, Chao Wang, Chun Zhang, China Trabectome Study Group
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=420;epage=425;aulast=Dang
_version_ 1818671218833752064
author Ya-Long Dang
Yu-Jie Cen
Ying Hong
Ping Huang
Ning-Li Wang
Chao Wang
Chun Zhang
China Trabectome Study Group
author_facet Ya-Long Dang
Yu-Jie Cen
Ying Hong
Ping Huang
Ning-Li Wang
Chao Wang
Chun Zhang
China Trabectome Study Group
author_sort Ya-Long Dang
collection DOAJ
description Background: The aim of the study was to evaluate the long-term safety and efficacy of the Trabectome for Chinese glaucoma patients. Methods: This was a multicenter, retrospective, observational study. Glaucoma patients, except those with neovascular glaucoma, with/without a visually significant cataract were enrolled. The patients received Trabectome or a combined surgery with phacoemulsification and intraocular lens implantation. The primary outcome evaluation was a reduction in intraocular pressure (IOP), and the secondary outcomes were a reduction in glaucoma medication, the 2-year success percentages, and complications. Success was defined as an IOP <21 mmHg and at least a 20% IOP reduction from baseline after 3 months for any two consecutive visits, without additional glaucoma surgery. The data were processed using the R Stats Package version 3.0.0. The Wilcoxon test was used to compare the postoperative IOP and the number of glaucoma medications with baselines. The Kaplan–Meier test was used to calculate the 2-year success percentage. The risk factors related to Trabectome failure were determined by logistic regression. Results: A total of 120 glaucoma patients were enrolled. The Trabectome efficiently reduced the IOP from a baseline of 22.8 ± 1.34 mmHg to 17.6 ± 0.96 mmHg, and the use of glaucoma medications from 2.2 ± 0.17 mmHg to 1.4 ± 0.21 in a 2-year follow-up (both, P < 0.01). The overall success percentage was 80%. No risk factor related to Trabectome failure was identified. No vision-threatening complication was observed. Ten patients, who required secondary glaucoma surgery, all reached the target IOP. Conclusions: In a 2-year follow-up, Trabectome was an efficient and safe procedure for Chinese glaucoma patients.
first_indexed 2024-12-17T07:20:31Z
format Article
id doaj.art-b10bc0b7e892479db957c902f50646b1
institution Directory Open Access Journal
issn 0366-6999
language English
last_indexed 2024-12-17T07:20:31Z
publishDate 2018-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-b10bc0b7e892479db957c902f50646b12022-12-21T21:58:47ZengWolters KluwerChinese Medical Journal0366-69992018-01-01131442042510.4103/0366-6999.225050Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre StudyYa-Long DangYu-Jie CenYing HongPing HuangNing-Li WangChao WangChun ZhangChina Trabectome Study GroupBackground: The aim of the study was to evaluate the long-term safety and efficacy of the Trabectome for Chinese glaucoma patients. Methods: This was a multicenter, retrospective, observational study. Glaucoma patients, except those with neovascular glaucoma, with/without a visually significant cataract were enrolled. The patients received Trabectome or a combined surgery with phacoemulsification and intraocular lens implantation. The primary outcome evaluation was a reduction in intraocular pressure (IOP), and the secondary outcomes were a reduction in glaucoma medication, the 2-year success percentages, and complications. Success was defined as an IOP <21 mmHg and at least a 20% IOP reduction from baseline after 3 months for any two consecutive visits, without additional glaucoma surgery. The data were processed using the R Stats Package version 3.0.0. The Wilcoxon test was used to compare the postoperative IOP and the number of glaucoma medications with baselines. The Kaplan–Meier test was used to calculate the 2-year success percentage. The risk factors related to Trabectome failure were determined by logistic regression. Results: A total of 120 glaucoma patients were enrolled. The Trabectome efficiently reduced the IOP from a baseline of 22.8 ± 1.34 mmHg to 17.6 ± 0.96 mmHg, and the use of glaucoma medications from 2.2 ± 0.17 mmHg to 1.4 ± 0.21 in a 2-year follow-up (both, P < 0.01). The overall success percentage was 80%. No risk factor related to Trabectome failure was identified. No vision-threatening complication was observed. Ten patients, who required secondary glaucoma surgery, all reached the target IOP. Conclusions: In a 2-year follow-up, Trabectome was an efficient and safe procedure for Chinese glaucoma patients.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=420;epage=425;aulast=DangGlaucoma; Intraocular Pressure; Minimally Invasive Surgical Procedures; Trabecular Meshwork
spellingShingle Ya-Long Dang
Yu-Jie Cen
Ying Hong
Ping Huang
Ning-Li Wang
Chao Wang
Chun Zhang
China Trabectome Study Group
Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
Chinese Medical Journal
Glaucoma; Intraocular Pressure; Minimally Invasive Surgical Procedures; Trabecular Meshwork
title Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
title_full Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
title_fullStr Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
title_full_unstemmed Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
title_short Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study
title_sort safety and efficiency of trabectome mediated trabecular meshwork ablation for chinese glaucoma patients a two year retrospective multicentre study
topic Glaucoma; Intraocular Pressure; Minimally Invasive Surgical Procedures; Trabecular Meshwork
url http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=420;epage=425;aulast=Dang
work_keys_str_mv AT yalongdang safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT yujiecen safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT yinghong safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT pinghuang safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT ningliwang safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT chaowang safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT chunzhang safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy
AT chinatrabectomestudygroup safetyandefficiencyoftrabectomemediatedtrabecularmeshworkablationforchineseglaucomapatientsatwoyearretrospectivemulticentrestudy